Incidence patterns and outcomes for Hodgkin lymphoma patients in the United States

Advances in Hematology

Volumn 2011, Issue , 2011, Pages

  Flowers, Christopher R ^a   Shenoy, Pareen ^a   Maggioncalda, Alison ^a   Malik, Neha ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE DETERMINATION; ARTICLE; ASIAN; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PATIENT; CANCER REGISTRY; CANCER RISK; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; EUROPEAN AMERICAN; HODGKIN DISEASE; HUMAN; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; SEX DIFFERENCE; TREATMENT OUTCOME; UNITED STATES;

EID: 79251548240     PISSN: 16879104     EISSN: 16879112     Source Type: Journal    
DOI: 10.1155/2011/725219     Document Type: Article

References (50)

1. Schnitzer B., Hodgkin lymphoma Hematology/Oncology Clinics of North America 2009 23 4 747 768
2. Burke J., Knowles D., Hodgkin's disease: histopathology and differential diagnosis Neoplastic Hematopathology 1992 Baltimore, Md, USA Williams and Wilkins 497 533
3. American Cancer Society, Cancer Facts Figures 2010. http://www.cancer. org/acs/groups/content/@nho/documents/document/acspc-024113.pdf
4. Devita V. T. Jr. , Serpick A. A., Carbone P. P., Combination chemotherapy in the treatment of advanced Hodgkin's disease Annals of Internal Medicine 1970 73 6 881 895
5. Brenner H., Gondos A., Pulte D., Ongoing improvement in long-term survival of patients with Hodgkin disease at all ages and recent catch-up of older patients Blood 2008 111 6 2977 2983
6. Glaser S. L., Hsu J. L., Hodgkin's disease in Asians: incidence patterns and risk factors in population-based data Leukemia Research 2002 26 3 261 269
7. Maggioncalda A., Malik N., Shenoy P., Smith M., Sinha R., Flowers C. R., Clinical, molecular, and environmental risk factors for hodgkin lymphoma Advances in Hematology 2011 2011 10
8. Ries L. A. G., Kosary C. L., Hankey B. F., Miller B. A., Harras A., Edwards B. K., SEER Cancer Statistics Review, 19731994 1997 Bethesda, Md, USA National Cancer Institute
9. Pulte D., Gondos A., Brenner H., Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 19902004 Journal of the National Cancer Institute 2008 100 18 1301 1309
10. Surveillance, Epidemiology, and End Results (SEER) Program (http://www.seer.cancer.gov/): SEERStat Database: IncidenceSEER 13 Regs Limited-Use, Nov 2009 Sub (19922007) Katrina/Rita Population AdjustmentLinked To County Attributes-Total U.S., 19692007 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2010, based on the November 2009 submission
11. Hankey B. F., Ries L. A., Edwards B. K., The surveillance, epidemiology, and end results program: a national resource Cancer Epidemiology Biomarkers and Prevention 1999 8 12 1117 1121
12. Surveillance, Epidemiology, and End Results (SEER) Program (http://www.seer.cancer.gov/): SEERStat Database: IncidenceSEER 17 Regs Limited-Use + Hurricane Katrina impacted Louisiana Cases, Nov 2009 Sub (20002007) Katrina/Rita Population AdjustmentLinked To County Attributes-Total U.S., 19692007 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2010, based on the November 2009 submission
13. Percy C. L., Berg J. W., Thomas L. B., Manual of Tumor Nomenclature and Coding 1968 New York, NY, USA American Cancer Society
14. ICD-O International Classification of Diseases for Oncology 1976 Geneva, Switzerland World Health Organization
15. Percy C. L., Berg J. W., Thomas L. B., International Classification of Diseases for Oncology 1990 Geneva, Switzerland World Health Organization
16. Harris N. L., Jaffe E. S., Stein H., Banks P. M., Chan J. K. C., Cleary M. L., Delsol G., De Wolf-Peeters C., Falini B., Gatter K. C., Grogan T. M., Isaacson P. G., Knowles D. M., Mason D. Y., Muller-Hermelink H.-K., Pileri S. A., Piris M. A., Ralfkiaer E., Warnke R. A., A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group Blood 1994 84 5 1361 1392
17. Jaffe E. S., Harris N. L., Stein H., Vardiman J. W., World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues 2001 Lyon, France IARC Press
18. Swerdlow S. H., Campo E., Harris N. L., WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008 4th Lyon, France IARC Press
19. Percy C., Fritz A., Ries L., Conversion of Neoplasms by Topography and Morphology from the International Classification of Diseases for Oncology 2001 3rd Second Edition to International Classification of Diseases for Oncology
20. Morton L. M., Wang S. S., Devesa S. S., Hartge P., Weisenburger D. D., Linet M. S., Lymphoma incidence patterns by WHO subtype in the United States, 19922001 Blood 2006 107 1 265 276
21. Fritz A., Percy C., Jack A., International Classification of Diseases for Oncology 2000 3rd Geneva, Switzerland World Health Organization
22. Morton L. M., Turner J. J., Cerhan J. R., Linet M. S., Treseler P. A., Clarke C. A., Jack A., Cozen W., Maynadi M., Spinelli J. J., Costantini A. S., Rdiger T., Scarpa A., Zheng T., Weisenburger D. D., Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph) Blood 2007 110 2 695 708
23. NAACCR Race and Ethnicity Work Group, NAACCR Asian Pacific Islander Identification Algorithm [NAPIIA v1.2.1] 2010 Springfield, Ill, USA North American Association of Central Cancer Registries
24. Ries L. A. G., Eisner M. P., Kosary C. L., Hankey B. F., Miller B. A., Clegg L., Mariotto A., Feuer E. J., Edwards B. K., SEER Cancer Statistics Review, 19752001 2004 Bethesda, Md, USA National Cancer Institute. http://seer.cancer.gov/csr/19752001/
25. Day J. C., Population Projections of the United States by Age, Sex, Race, and Hispanic Origin: 1995 to 2050 U.S. Bureau of the Census, Current Population Reports, P25-1130 1996 Washington, DC, USA U.S. Government Printing Office. http://www.census.gov/prod/1/pop/p25-1130/p251130.pdf
26. Brown C. C., The statistical comparison of relative survival rates Biometrics 1983 39 4 941 948
27. Clarke C. A., Undurraga D. M., Harasty P. J., Glaser S. L., Morton L. M., Holly E. A., Changes in cancer registry coding for lymphoma subtypes: reliability over time and relevance for surveillance and study Cancer Epidemiology Biomarkers and Prevention 2006 15 4 630 638
28. Clarke C. A., Glaser S. L., Prehn A. W., Age-specific survival after Hodgkin's disease in a population-based cohort (United States) Cancer Causes and Control 2001 12 9 803 812
29. Medeiros L. J., Greiner T. C., Hodgkin's disease Cancer 1995 75 1 357 369
30. Macmahon B., Epidemiological evidence of the nature of Hodgkin's disease Cancer 1957 10 5 1045 1054
31. Hjalgrim H., Rostgaard K., Johnson P. C.D., Shield L., Little A. -M., Ekstrom-Smedby K., Adami H. -O., Glimelius B., Hamilton-Dutoit S., Kane E., Malcolm Taylor G., McConnachie A., Ryder L. P., Sundstrom C., Andersen P. S., Chang E. T., Alexander F. E., Melbye M., Jarrett R. F., HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma Proceedings of the National Academy of Sciences of the United States of America 2010 107 14 6400 6405
32. Glaser S. L., Lin R. J., Stewart S. L., Ambinder R. F., Jarrett R. F., Brousset P., Pallesen G., Gulley M. L., Khan G., O'Grady J., Hummel M., Preciado M. V., Knecht H., Chan J. K. C., Claviez A., Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data International Journal of Cancer 1997 70 4 375 382
33. Cozen W., Hamilton A. S., Zhao P., Salam M. T., Deapen D. M., Nathwani B. N., Weiss L. M., Mack T. M., A protective role for early oral exposures in the etiology of young adult Hodgkin lymphoma Blood 2009 114 19 4014 4020
34. Keegan T. H. M., Glaser S. L., Clarke C. A., Gulley M. L., Craig F. E., DiGiuseppe J. A., Dorfman R. F., Mann R. B., Ambinder R. F., Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study Journal of Clinical Oncology 2005 23 30 7604 7613
35. Shenoy P. J., Malik N., Nooka A., Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States. Cancer. In press
36. Glaser S. L., Clarke C. A., Gulley M. L., Craig F. E., DiGiuseppe J. A., Dorfman R. F., Mann R. B., Ambinder R. F., Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the greater San Francisco bay area, 19881998 Cancer 2003 98 2 300 309
37. Biggar R. J., Jaffe E. S., Goedert J. J., Chaturvedi A., Pfeiffer R., Engels E. A., Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS Blood 2006 108 12 3786 3791
38. Oramasionwu C. U., Brown C. M., Ryan L., Lawson K. A., Hunter J. M., Frei C. R., HIV/AIDS disparities: the mounting epidemic plaguing US blacks Journal of the National Medical Association 2009 101 12 1196 1204
39. AbouYabis A. N., Shenoy P. J., Lechowicz M. J., Flowers C. R., Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States Leukemia and Lymphoma 2008 49 11 2099 2107
40. Shenoy P. J., Bumpers K., King N., Black/white differences in the treatment and outcomes of diffuse large b cell lymphoma: a matched cohort analysis ASH Annual Meeting Abstracts 2009 114 22 1392
41. Wang M., Burau K. D., Fang S., Wang H., Du X. L., Ethnic variations in diagnosis, treatment, socioeconomic status, and survival in a large population-based cohort of elderly patients with non-Hodgkin lymphoma Cancer 2008 113 11 3231 3241
42. Hasenclever D., Diehl V., A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease The New England Journal of Medicine 1998 339 21 1506 1514
43. Gobbi P. G., Levis A., Chisesi T., Broglia C., Vitolo U., Stelitano C., Pavone V., Cavanna L., Santini G., Merli F., Liberati M., Baldini L., Deliliers G. L., Angelucci E., Bordonaro R., Federico M., ABVD versus modified Stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi Journal of Clinical Oncology 2005 23 36 9198 9207
44. Engert A., Franklin J., Eich H. T., Brillant C., Sehlen S., Cartoni C., Herrmann R., Pfreundschuh M., Sieber M., Tesch H., Franke A., Koch P., De Wit M., Paulus U., Hasenclever D., Loeffler M., Mller R.-P., Mller-Hermelink H. K., Dhmke E., Diehl V., Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial Journal of Clinical Oncology 2007 25 23 3495 3502
45. Hoskin P. J., Lowry L., Horwich A., Jack A., Mead B., Hancock B. W., Smith P., Qian W., Patrick P., Popova B., Pettitt A., Cunningham D., Pettengell R., Sweetenham J., Linch D., Johnson P. W.M., Randomized comparison of the Stanford V regimen and ABVD in the treatment of advanced Hodgkin's lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244 Journal of Clinical Oncology 2009 27 32 5390 5396
46. Duggan D. B., Petroni G. R., Johnson J. L., Glick J. H., Fisher R. I., Connors J. M., Canellos G. P., Peterson B. A., Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an Intergroup trial Journal of Clinical Oncology 2003 21 4 607 614
47. Canellos G. P., Nadler L., Takvorian T., Autologous bone marrow transplantation in the treatment of malignant lymphoma and Hodgkin's disease Seminars in Hematology 1988 25 2 58 65
48. Bonadonna G., Santoro A., ABVD chemotherapy in the treatment of Hodgkin's disease Cancer Treatment Reviews 1982 9 1 21 35
49. Canellos G. P., Anderson J. R., Propert K. J., Nissen N., Cooper M. R., Henderson E. S., Green M. R., Gottlieb A., Peterson B. A., Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD The New England Journal of Medicine 1992 327 21 1478 1484
50. Provencio M., Milln I., Espaa P., Snchez A. C., Snchez J. J., Cantos B., Vargas J. A., Bellas C., Garca V., Sabin P., Bonilla F., Analysis of competing risks of causes of death and their variation over different time periods in hodgkin's disease Clinical Cancer Research 2008 14 16 5300 5305